592
Views
63
CrossRef citations to date
0
Altmetric
Review Article

Nanosponges – a completely new nano-horizon: pharmaceutical applications and recent advances

, &
Pages 1263-1272 | Received 12 Sep 2011, Accepted 14 May 2012, Published online: 11 Jun 2012

References

  • Patel M, Patel R, Shah D. Applications of cyclodextrin in drug delivery. Int J of Pharma World Research. 2010;1:1–16.
  • Weltrowski M, Morcellet M, Martel B. Cyclodextrin polymer and /or cyclodextrin derivatives with complexing properties and ion-exchange properties and method for the production thereof. 2003; US 6660804 B1.
  • Martin del valle EM. Cyclodextrin and their uses: a review. Process Biochem. 2004;39:1033–1046.
  • Szetjli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev 1998;98:1743–1753.
  • Szejtli J. Past, present and future of cyclodextrin research. Pure Appl Chem 2004;76:1825–1845.
  • Salazar T. Nanosponges soak up contaminants and cut cleanup Costs dateline. Los Alamos, April issue 1998, Los Alamos, A Monthly publication of the public affairs office of Los Alamos national laboratory. 1998;1–3.
  • Baldvinsdóttir J, Ingvarsdóttir K, Kristmundsdóttir T, Loftsson T, Ólafsdóttir B. Preparation and physical evaluation of microcapsules of hydrophilic drug-cyclodextrin complexes. J Microencapsulation 1992;9:375–382.
  • Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Inclusion Phenom Macrocyclic Chem. 2006;56:209–213.
  • Swaminathan S, Torne S, Trotta F, Vavia PR. Formulation of β-cyclodextrin based nanosponges of itraconazole. J Inclusion Phenom Macrocyclic Chem. 2007;57:89–94.
  • Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D et al. (2010). Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm, 74:193–201.
  • Cavalli R, Ferruti P, Gerges I, Manfredi A, Ranucci E, Trotta F, Vavia PR et al.In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. J Inclusion Phenom Macrocyclic Chem. 2010;68:183–191.
  • Aynie C, Chacun E, Fattal P, Vauthier H. Couvreur P, Sponge like alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev.1999;9:301–312.
  • Ansari KA, Vavia PR, Trotta F, Cavalli R. (2011). Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech, 12:279–286.
  • Chu YH, Yamagishi M, Wang ZM, Kanoh H, Hirotsu T. (2007). Adsorption characteristics of nanoporous carbon-silica composites synthesized from graphite oxide by a mechanochemical intercalation method. J Colloid Interface Sci, 312:186–192.
  • Cavalli R, Trotta F, Tumiatti W. Ultra sound assisted synthesis of cyclodextrin-based nanosponges. 2006; WO 2006/002814.
  • Ahuja A, Ali J, Challa R, Khar RK. Cyclodextrins in drug delivery: an update review. AAPS PharmSciTech 2,6. Article 43 2005;E329–E357.
  • Nangia A. Organic nanoporous structure. Curr Opin Solid State Mater Sci 2001;5:115–122.
  • Alongi J, Frache A, Poskovic M, Trotta F. Novel flame retardants containing cyclodextrin nanosponges and phosphorus compounds to enhance EVA combustion properties. Polym Degrad Stab 2010;95:2093–2100.
  • Castiglione F, Ganazzoli F, Malpezzi L, Mele A, Raffaini G, Trotta F, et al. HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in β-CD nanosponges. J Inclusion Phenom Macrocyclic Chem. 2010;69:403–409.
  • Pathak K, Sharma R. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 2011;16:367–376.
  • Du Y, John F, Lin B, Luo J, Wang X. Chitosan/organic rectorite nanocomposite films: Structure, characteristic and drug delivery behaviour. Carbohydr Polym 2007;69:41–49.
  • Ansari K, Bisazza A, Cavalli R, Giusetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. Int J Pharm. 2010;402:254–257.
  • Ganazzoli F, Castiglione F, Mele A, Raffaini G. A molecular dynamics study of cyclodextrin nanosponge models. J Incl Phenom Macrocycl Chem. 2012; doi 10.1007/s10847-012-0126-8.
  • Castiglione V, Crupi D, Majolino D, Mele A, Panzeri W. et al. Vibrational dynamics and hydrogen bond properties of β-CD nanosponges: an FTIR-ATR, Raman and solid-state NMR spectroscopic study. J Incl Phenom Macrocycl Chem. 2012; doi 10.1007/s10847-012-0106-z
  • Allabashia R, Arkasb M, Ho¨rmanna G, Tsiourvasb D. Removal of some organic pollutants in water employing ceramic membranes impregnated with cross-linked silylated dendritic and cyclodextrin polymers. Water Res. 2007;41:476–486.
  • Devecchi M, Martina K, Roggero C, Seglie L, Trotta F et al. The effects of 1-MCP in cyclodextrin-based nanosponges to improve the vase life of Dianthus caryophyllus cut flowers. Posthavest Biol Technol 2011;59:200–205.
  • Boscolo B, Ghibaudi E, Trotta F. High catalytic performances of Pseudomonas fluorescens lipase adsorbed on a new type of cyclodextrin-based nanosponges. J Mol Catal B: Enzym 2010;62:155–161.
  • Cavalli R, Trotta F. Characterization and application of new hyper-cross-linked cyclodextrin. Composite Interfaces. 2009;16:39–48.
  • Torne S, Darandale S, Vavia P, Trotta F, Cavalli R. (2012). Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol, doi:10.3109/10837450.2011:649855.
  • Ansari K, Cavalli R, Torne SJ, Trotta F, Vavia P. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Delivery. 2010;17:419–425.
  • Corrigan OI, Healy AH, Li J, Nolan LM, Tajber L. Particle engineering of materials for oral inhalation by dry powder inhalers II Sodium cromoglicate. Int J Pharm 2011;405:36–46.
  • Harth E, Diaz R. Nanosponge drug delivery system more effective than direct injection. Nanotechnology Now. [Online] 2010. Available at: http://www.vanderbilt.edu/exploration/stories/nanosponge.html. Accessed on 11 May 2012.
  • Corrigan OI, Healy AM, McDonald BF, Tajber L. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur J Pharm Biopharm. 2008;69:1182–1186.
  • Barham AS, Corrigan OI, Lorraine MN, McDonald BF, Tajber L. et al. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. Eur J Pharm Sci 2009;37:593–602.
  • Corrigan OI, Healy AH, Li J, Nolan LM, Tajber L. Particle engineering of materials for oral inhalation by dry powder inhalers. I—Particles of sugar excipients (trehalose and raffinose) for protein delivery. Int J Pharm. 2010;405:23–35
  • Ansari K, Biasizzo M, Bordiga S, Cavalli R, Martina K, Trotta F. et al. Cyclodextrin nanosponges as effective gas carriers. J Inclusion Phenom Macrocyclic Chem 2011;71:189–194.
  • Holdich JJ, Malik DJ, Ramsden GL, Warwick IR, Webb RG. et al. Synthesis and characterization of size-selective nanoporous polymeric adsorbents for blood purification. Sep Purif Technol. 2009;66:578–585.
  • Foley HC, Tapan NS, Zydney AL. Development and characterization of nanoporous carbon membranes for protein ultrafiltration. J Membr Sci. 2007;295:40–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.